<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="http://www.valueinvestingnews.com" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
 <title>Value Investing News - Pfizer Moat Check - Comments</title>
 <link>http://www.valueinvestingnews.com/pfizer-moat-check</link>
 <description>Comments for &quot;Pfizer Moat Check&quot;</description>
 <language>en</language>
<item>
 <title>Pfizer Moat Check</title>
 <link>http://www.valueinvestingnews.com/pfizer-moat-check</link>
 <description>A look at the factors that give drug giant Pfizer a wide moat and how that competitive advantage has been playing out in this companies fundamentals.</description>
 <comments>http://www.valueinvestingnews.com/pfizer-moat-check#comments</comments>
 <category domain="http://www.valueinvestingnews.com/category/stock-analysis">Stock Analysis</category>
 <category domain="http://www.valueinvestingnews.com/stock-tickers/pfe">PFE</category>
 <pubDate>Tue, 12 Dec 2006 11:32:17 -0500</pubDate>
 <dc:creator>George</dc:creator>
 <guid isPermaLink="false">416 at http://www.valueinvestingnews.com</guid>
</item>
</channel>
</rss>
